Stockwell Lynn

Drugs Made In America Acquisition Corp. Units · CEO and Exe. Chair of Board

Stockwell Lynn is listed in public filings as director, 10 percent owner, officer: CEO and Exe. Chair of Board. This Stockwell Lynn insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Drugs Made In America Acquisition Corp. Units (DMAAU). Investors use Stockwell Lynn's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

History Trades

CompanyValueActionPriceCurrent Price
Drugs Made In America Acquisition Corp. UnitsDMAAU$8.5M5.7M sharesSellJan 29, 2025$1.50--
Drugs Made In America Acquisition Corp. UnitsDMAAUDisclosure amount unavailable400k sharesBuyJan 29, 2025----